Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05908409
Title A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Acronym CASSANDRA
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors IDP Discovery Pharma S.L.
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.